Printer Friendly

ALPHA 1 BIOMEDICALS ANNOUNCES 1991 FINANCIAL RESULTS

 ALPHA 1 BIOMEDICALS ANNOUNCES 1991 FINANCIAL RESULTS
 WASHINGTON, March 27 /PRNewswire/ -- Alpha 1 Biomedicals, Inc.


(NASDAQ: ALBM) today reported financial results for calendar year 1991.
 For comparison purposes, the company changed its fiscal year end from March 31 to Dec. 31, effective Dec. 31, 1990, thereby creating a nine month transitional period covering April 1, 1990 through Dec. 31, 1990.
 Revenues for the year ended Dec. 31, 1991 were $707,353 as compared to $360,004 for the transitional period ended Dec. 31, 1990, primarily as a result of increased revenue from sales of rights and licenses and increased interest income.
 Expenses for the year ended Dec. 31, 1991 were $3,206,423 as compared to $2,008,731 for the transitional period ended Dec. 31, 1990 which were primarily attributable to increased research and development activities associated with the conduct of ongoing clinical trials and increased administrative expenses.
 Reported losses for the year ended Dec. 31, 1991 were $2,499,070 or $.38 per share as compared to $1,648,727 or $.30 per share for the transitional period ended Dec. 31, 1990. Expenses were in line with company expectations, while revenues were somewhat higher resulting in a loss that was somewhat less than projected.
 Alpha 1 Biomedicals, Inc. is a Washington, D.C.-based company engaged in the development of pharmaceutical products.
 ALPHA 1 BIOMEDICALS, INC.
 Nine month
 Year ended transitional period ended
 12/31/91 12/31/90
 Total revenue $ 707,353 $ 360,004
 Total expenses $3,206,423 $2,008,731
 Net loss $2,499,070 $1,648,727
 Net loss per com. share .38 .30
 Weighted avg. no. of com.
 shares outstanding 6,512,903 5,532,601
 -0- 3/27/92
 /CONTACT: Robert J. Lanhan of Alpha 1 Biomedicals, 202-628-9898/
 (ALBM) CO: Alpha 1 Biomedicals, Inc. ST: District of Columbia IN: MTC SU: ERN


KD-AH -- NY056 -- 2512 03/27/92 16:38 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 27, 1992
Words:319
Previous Article:CRUM AND FORSTER DISCUSSES POSSIBLE SALE OF CONSTITUTION REINSURANCE TO SCOR U.S. CORPORATION
Next Article:ICN BIOMEDICALS INC. INCREASES QUARTERLY DIVIDEND 13 PERCENT
Topics:


Related Articles
ICN BIOMEDICALS INC. ANNOUNCES RESTRUCTURING
ICN BIOMEDICALS REPORTS THIRD QUARTER RESULTS
ICN BIOMEDICALS REPORTS WRITE-OFFS
ALPHA 1 BIOMEDICALS, INC. FIRST QUARTER CALENDAR YEAR 1993 RESULTS
ALPHA 1 BIOMEDICALS SECOND QUARTER, CALENDAR YEAR 1993 RESULTS
ICN BIOMEDICALS REPORTS PROFIT IN 1993
ICN BIOMEDICALS REPORTS PROFIT IN 1993
ALPHA 1 BIOMEDICALS, INC. CALENDAR YEAR 1995 RESULTS
Alpha 1 Biomedicals, Inc. Calendar Year 1996 Results
Alpha 1 Biomedicals, Inc. Third Quarter Calendar Year 1997 Results

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters